Aberrant Expression of E-cadherin in Lung Tissues of Patients with Probable Lung Cancer |
Yuan, Yu-Lin
(Department of Clinical Laboratory, The Second Xiangya Hospital, Central South University)
Wang, Yu-Ming (Department of Clinical Laboratory, The First Affilliated Hospital of Kunming Medical University) Liu, Hua (Department of Clinical Laboratory, The First Affilliated Hospital of Kunming Medical University) Qin, Gui-Fang (Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region) Tang, Ai-Guo (Department of Clinical Laboratory, The Second Xiangya Hospital, Central South University) Duan, Yong (Department of Clinical Laboratory, The First Affilliated Hospital of Kunming Medical University) |
1 | Ahmedin Jemal DVM, Freddie Bray, Melissa M, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90. DOI |
2 | Brambilla E, Travis WD, Colby TV, et al (2001). The new World Health Organization classification of lung tumours. Eur Respir J, 18, 1059-68. DOI ScienceOn |
3 | Bukholm IK, Nesland JM, Karesen R, et al (1998). E-cadherin and alpha-, beta- and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol, 185, 262-6. DOI ScienceOn |
4 | Comijn J, Berx G, Vermassen P, et al (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell, 7, 1267-78. DOI ScienceOn |
5 | Demirci U, Ozdemir N, Benekli M, et al (2012). Lymphoproliferative disorders in multiple primary cancers. Asian Pac J Cancer Prev, 13, 383-6. DOI ScienceOn |
6 | Feng QH, Hawes SE, Stern JE, et al (2008). DNA Methylation in Tumor and Matched Normal Tissues from Non-Small Cell Lung Cancer Patients. Cancer Epidemiol Biomarkers Prev, 17, 645-54. DOI |
7 | Guo HM, Zhang XQ, Xu CH, et al (2011). Expression of E-cadherin and alpa-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Asian Pac J Cancer Prev, 12, 3433-8. |
8 | Hennig G, Behrens J, Truss M, et al (1995). Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene, 11, 475-84. |
9 | Herbst RS, Yano S, Kuniyasu H, et al (2000). Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res, 6, 690-7. |
10 | Hirata T, Fukuse T, Naiki H, et al (2001). Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer. Clin Lung Cancer, 3, 134-40. DOI |
11 | Hirohashi S (1998). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol, 153, 333-9. DOI |
12 | Kimman M, Norman R, Jan S, et al (2012). The burden of cancer in member countries of the association of southeast asian nations (ASEAN). Asian Pac J Cancer Prev, 13, 411-20. 과학기술학회마을 DOI |
13 | Li WT, Liu CL, Tang Y, et al (2011). Overexpression of snail accelerates adriamycin induction of multidrug resistance in breast cancer cells. Asian Pac J Cancer Prev, 12, 2575-80. |
14 | Liu D, Huang D, Kameyama K, et al (2001). E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg, 71, 949-55. DOI ScienceOn |
15 | Paras J, Mushal N, Robert G, et al (2008). Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol, 14, 1044-52. DOI |
16 | Mir MR, Shabir N, Wani KA, et al (2012). Association between p16, Hmlh1 and E-cadherin promoter hypermethylation and intake of local hot salted tea and sun-dried foods in Kashmiris with gastric tumors. Asian Pac J Cancer Prev, 13, 181-6. 과학기술학회마을 DOI ScienceOn |
17 | Mitselou A, Batistatou A, Nakanishi Y, et al (2010). Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites. Histol Histopathol, 25, 1257-67. |
18 | Oda H, Takeichi M (2011). Evolution: structural and functional diversity of cadherin at the adherens junction. J Cell Biol, 193, 1137-46. DOI |
19 | Perez-Moreno MA, Locascio A, Rodrigo I, et al (2001). A new role for E12/E47 in the repression of E-cadherin expression and epithelial- mesenchymal transitions. J Biol Chem, 276, 27424-31. DOI |
20 | Ramezani F, Salami S, Omrani MD, et al (2012). CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. Asian Pac J Cancer Prev, 13, 451-7. 과학기술학회마을 DOI ScienceOn |
21 | Schmidt CR, Gi YJ, Patel TA, et al (2005). E-cadherin is regulated by the transcriptional repressor SLUG during Ras-mediated transformation of intestinal epithelial cells. Surgery, 138, 306-12. DOI |
22 | Shibanuma H, Hirano T, Tsuji K, et al (1998). Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer. Lung Cancer, 22, 85-95. DOI ScienceOn |
23 | Tamura G, Yin J, Wang S, et al (2000). E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst, 92, 569-73. DOI ScienceOn |
24 | Shuang Y, Jun D, Zhaoqi W, et al (2007). BMP-6 promotes E-cadherin expression through repressing δEF1 in breast cancer cells. BMC Cancer, 7, 211 DOI ScienceOn |
25 | Stefanou D, Goussia AC, Arkoumani E, et al (2003). Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer. Anticancer Res, 23, 4715-20. |
26 | Sun HH, Cui H, Jin YM, et al (2011). Genetic analysis of liver metastatic cell lines with different metastatic potential. Asian Pac J Cancer Prev, 12, 3257-63. |
27 | Umbas R, Schalken JA, Aalders TW, et al (1992). Expression of the cellular adhesion molecue E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res, 52, 5104-9. |
28 | van Roy F, Berx G (2008). The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci, 65, 3756-88. DOI |
29 | Yu T, Hou FG, Liu MM, et al (2012). Norcantharidin antiangiogenesis activity possibly through an endothelial cell pathway in human colorectal cancer. Asian Pac J Cancer Prev, 13, 499-503. DOI |
![]() |